Clinical Report: Trends in the Incidence of Aplastic Anaemia Across Kazakhstan
Overview
This study analyzes the incidence trends of aplastic anaemia (AA) in Kazakhstan from 2014 to 2024, revealing a significant increase in cases, particularly idiopathic AA. The findings highlight regional variations in incidence rates.
Background
Aplastic anaemia is a rare but serious hematologic disorder that can lead to severe complications and high mortality if untreated. Understanding its epidemiology is crucial for effective healthcare planning and resource allocation, particularly in regions with limited data like Kazakhstan. This study provides insights into the incidence and characteristics of AA in the country.
Data Highlights
Year
Incidence Rate (per 100,000)
2014
0.21
2024
0.82
Key Findings
A total of 1,209 incident cases of AA were identified from 2014 to 2024.
The median age of patients was 26 years, with a slight female predominance (52.3%).
88.9% of cases were classified as idiopathic or unspecified.
The national incidence of AA increased from 0.21 per 100,000 in 2014 to 0.82 per 100,000 in 2024.
Regional variation was noted, with urban centers having the highest incidence rates (up to 1.48 per 100,000 in 2024).
Secondary AA cases remained stable and uncommon during the study period.
Clinical Implications
The increase in idiopathic aplastic anaemia cases suggests a need for enhanced surveillance and diagnostic efforts in Kazakhstan. Addressing geographic disparities in healthcare access may improve early detection and management of AA.
Conclusion
The study indicates a rising trend in aplastic anaemia incidence in Kazakhstan, primarily driven by idiopathic cases.
